These results suggest that the molecular disease mechanism for the CPVT-causing CaM mutations is dysregulation of cardiac SR Ca2+ release, in line with CPVT-causing mutations in RyR2. Here, CALM1 is linked to catecholaminergic polymorphic ventricular tachycardia.